Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAWNA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,696
Award facts
- Contract value 100% obligated
- $31,695.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $31,695.87 by the Defense Logistics Agency on September 17, 2025. The contract calls for the delivery of Xeljanz XR 11 mg tablets in quantities of 30 units, with an ultimate completion date of September 18, 2025. The award utilized no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026.
The Defense Logistics Agency, operating under the Department of Defense, utilizes this IDC framework to procure a comprehensive range of pharmaceutical products supporting medical supply needs across military healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent performance on delivery orders covering prescription medications, biologics, and medical consumables. The performance location for this delivery order is Conshohocken, Pennsylvania, indicating the fulfillment location for the pharmaceutical product being supplied to support Defense Department healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAWNA?
SPE2DB25FAWNA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FAWNA worth?
The government has obligated $31,696 on SPE2DB25FAWNA.
Is contract SPE2DB25FAWNA an order under another contract?
Yes. SPE2DB25FAWNA is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWNA competed?
The extent of competition for SPE2DB25FAWNA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award